duloxetine

Inventia Healthcare Private Limited🇺🇸 United States

FDA Page

Effective Date: Sep 18, 2025
Approval ID: eab90059-ea1c-46c1-884d-c15e7c562a01
Products: 3 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DULOXETINE DELAYED RELEASE CAPSULES, USP safely and effectively. See full prescribing information for DULOXETINE DELAYED RELEASE CAPSULES, USP. DULOXETINE delayed-release capsules, for oral use. Initial U.S. Approval:2004

Quick Stats

Total Products3

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.